BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE) — FDA Approval ANDA208992 (SOMERSET THERAPS LLC)
BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE) — FDA Approval ANDA208992 (SOMERSET THERAPS LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BRIMONIDINE TARTRATE; Active ingredients: BRIMONIDINE TARTRATE; Application number: ANDA208992.
| Brand name | BRIMONIDINE TARTRATE |
|---|---|
| Active ingredients | BRIMONIDINE TARTRATE |
| Application number | ANDA208992 |
| Sponsor | SOMERSET THERAPS LLC |
| Dosage form | SOLUTION/DROPS |
| Route | OPHTHALMIC |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20190311 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →